The FDA granted Biom’up’s Hemoblast Bellows laparoscopic applicator marketing approval for all minimally-invasive procedures.
The approval expands the device’s indications and allows surgeons to use the hemostatic powder in both traditional and laparoscopic surgeries.
The device is used to quickly deliver Hemoblast powder to bleeding areas in minimally-invasive surgeries, providing control of minimal, mild and moderate blood flows.
